Biogen's most recent trend suggests a bearish bias. One trading opportunity on Biogen is a Bear Call Spread using a strike $250.00 short call and a strike $260.00 long call offers a potential 9.89% return on risk over the next 23 calendar days. Maximum profit would be generated if the Bear Call Spread were to expire worthless, which would occur if the stock were below $250.00 by expiration. The full premium credit of $0.90 would be kept by the premium seller. The risk of $9.10 would be incurred if the stock rose above the $260.00 long call strike price.
The 5-day moving average is moving down which suggests that the short-term momentum for Biogen is bearish and the probability of a decline in share price is higher if the stock starts trending.
The 20-day moving average is moving down which suggests that the medium-term momentum for Biogen is bearish.
The RSI indicator is at 49.31 level which suggests that the stock is neither overbought nor oversold at this time.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for Biogen
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biogen Inc. – BIIB
Tue, 24 Nov 2020 03:00:00 +0000
NEW YORK, NY / ACCESSWIRE / November 23, 2020 / Pomerantz LLP is investigating claims on behalf of investors of Biogen Inc.
BIIB ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of January 12, 2021 in the Class Action Filed on Behalf of Biogen Inc. Limited Shareholders
Tue, 24 Nov 2020 00:47:00 +0000
New York, New York–(Newsfile Corp. – November 23, 2020) – The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Biogen Inc. (NASDAQ: BIIB) alleging that the Company violated federal securities laws.Class Period: October 22, 2019 and November 6, 2019Lead Plaintiff Deadline: January 12, 2021Learn more about your recoverable losses in BIIB:http://www.kleinstocklaw.com/pslra-1/biogen-inc-loss-submission-form?id=11159&from=5The filed complaint alleges that Biogen Inc. made materially false and/or misleading statements and/or failed …
DEADLINE FOR BIIB INVESTORS: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Biogen Inc.
Mon, 23 Nov 2020 23:21:00 +0000
New York, New York–(Newsfile Corp. – November 23, 2020) – Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the securities of Biogen Inc. (“Biogen” or the “Company”) (NASDAQ: BIIB) from October 22, 2019 through November 6, 2020 (the “Class Period”). The lawsuit filed in …
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of PT, BTU and BIIB
Mon, 23 Nov 2020 21:45:00 +0000
NEW YORK, NY / ACCESSWIRE / November 23, 2020 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly-traded companies.
IMPORTANT INVESTOR DEADLINE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Biogen Inc. and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm
Mon, 23 Nov 2020 20:55:00 +0000
LOS ANGELES, CA / ACCESSWIRE / November 23, 2020 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Biogen Inc.
Also on Market Tamer…
Follow Us on Facebook